Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2021 4
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Reply to Agrawal and Kumar.
Kansagra K, Parmar D, Mendiratta SK, Patel J, Joshi S, Sharma N, Parihar A, Bhoge S, Patel H, Kalita P, Munshi R, Kurmi P, Shah R, Gupta A, Bhalla HL, Bekkalele H, Verma RK, Agarwal D, Sharma S, Gawande A, Chhaya G. Kansagra K, et al. Among authors: mendiratta sk. Clin Infect Dis. 2021 Aug 2;73(3):e846. doi: 10.1093/cid/ciaa1507. Clin Infect Dis. 2021. PMID: 33011769 No abstract available.
Rituximab biosimilar for the treatment of diffuse large B-cell lymphoma: a phase 3 randomized study in India.
Patel A, Bhatt N, Prakash SS, Biswas G, Nagarkar R, Roy B, Samal P, Agrawal N, Meshram S, Kaushal A, Satheesh CT, Wategaonkar R, Thiagarajan KV, Jain K, Vijayaveeran P, Mukherjee K, Singh K, Patil T, Jain A, Dolai TK, Jain M, Hingmire S, Gupta TC, Lakshmaiah KC, Rajamanickam D, Nemade B, Goyal V, Mahato P, Mendiratta SK, Doshi M. Patel A, et al. Among authors: mendiratta sk. Cancer Chemother Pharmacol. 2023 Jun;91(6):457-468. doi: 10.1007/s00280-023-04530-x. Epub 2023 Apr 24. Cancer Chemother Pharmacol. 2023. PMID: 37093266 Free PMC article. Clinical Trial.
Efficacy and safety of pegylated interferon-α2b in moderate COVID-19: a phase 3, randomized, comparator-controlled, open-label study.
Bhushan B L S, Wanve S, Koradia P, Bhomia V, Soni P, Chakraborty S, Khobragade A, Joshi S, Mendiratta SK, Kansagra KK, Parihar A, Sharma S, Patel J; Study Investigators Group. Bhushan B L S, et al. Among authors: mendiratta sk. Int J Infect Dis. 2021 Oct;111:281-287. doi: 10.1016/j.ijid.2021.08.044. Epub 2021 Aug 21. Int J Infect Dis. 2021. PMID: 34428542 Free PMC article. Clinical Trial.
A Phase 3, Randomized, Open-label, Noninferiority Trial Evaluating Anti-Rabies Monoclonal Antibody Cocktail (TwinrabTM) Against Human Rabies Immunoglobulin (HRIG).
Kansagra K, Parmar D, Mendiratta SK, Patel J, Joshi S, Sharma N, Parihar A, Bhoge S, Patel H, Kalita P, Munshi R, Kurmi P, Shah R, Gupta A, Bhalla H, Bekkalele H, Verma R, Agarwal D, Sharma S, Gawande A, Chhaya G. Kansagra K, et al. Among authors: mendiratta sk. Clin Infect Dis. 2021 Nov 2;73(9):e2722-e2728. doi: 10.1093/cid/ciaa779. Clin Infect Dis. 2021. PMID: 32556113 Clinical Trial.
Recent progress in polymeric gene delivery systems.
Anwer K, Rhee BG, Mendiratta SK. Anwer K, et al. Among authors: mendiratta sk. Crit Rev Ther Drug Carrier Syst. 2003;20(4):249-93. doi: 10.1615/critrevtherdrugcarriersyst.v20.i4.10. Crit Rev Ther Drug Carrier Syst. 2003. PMID: 14635981 Review.